Evidence map›Paper›PMID 29525279›Full record

ArticleVaccine2018

Assessment of temporally-related acute respiratory illness following influenza vaccination.

Sharon Rikin, Haomiao Jia, Celibell Y Vargas, Yaritza Castellanos de Belliard, Carrie Reed, Philip LaRussa, Elaine L Larson, Lisa Saiman, Melissa S Stockwell

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Annual flu shot: Does it help patients with COVID-19?International journal of clinical practice · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sharon RikinDepartment of Medicine, Columbia University, New York, NY, USA.
Haomiao JiaSchool of Nursing, Columbia University, New York, NY, USA; Mailman School of Public Health, Columbia University, New York, NY, USA.
Celibell Y VargasDepartment of Pediatrics, Columbia University, New York, NY, USA.
Yaritza Castellanos de BelliardDepartment of Pediatrics, Columbia University, New York, NY, USA.
Carrie ReedCenters for Disease Control and Prevention, Atlanta, GA, USA.
Philip LaRussaDepartment of Pediatrics, Columbia University, New York, NY, USA.
Elaine L LarsonSchool of Nursing, Columbia University, New York, NY, USA; Mailman School of Public Health, Columbia University, New York, NY, USA.
Lisa SaimanDepartment of Pediatrics, Columbia University, New York, NY, USA; NewYork-Presbyterian Hospital, New York, NY, USA.
Melissa S StockwellMailman School of Public Health, Columbia University, New York, NY, USA; Department of Pediatrics, Columbia University, New York, NY, USA; NewYork-Presbyterian Hospital, New York, NY, USA. Electronic address: mss2112@columbia.edu.
Columbia University · USCenters for Disease Control and Prevention · US

Funding

MOSAIC: Mobile Surveillance for ARI and ILI in the CommunityU01IP000618 · IP · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STOCKWELL, MELISSA S · 2012 to 2016
$6.0M
NCIRD CDC HHS U01 IP000618
6 · The paper itself

Abstract

backgroundA barrier to influenza vaccination is the misperception that the inactivated vaccine can cause influenza. Previous studies have investigated the risk of acute respiratory illness (ARI) after influenza vaccination with conflicting results. We assessed whether there is an increased rate of laboratory-confirmed ARI in post-influenza vaccination periods.

methodsWe conducted a cohort sub-analysis of children and adults in the MoSAIC community surveillance study from 2013 to 2016. Influenza vaccination was confirmed through city or hospital registries. Cases of ARI were ascertained by twice-weekly text messages to household to identify members with ARI symptoms. Nasal swabs were obtained from ill participants and analyzed for respiratory pathogens using multiplex PCR. The primary outcome measure was the hazard ratio of laboratory-confirmed ARI in individuals post-vaccination compared to other time periods during three influenza seasons.

resultsOf the 999 participants, 68.8% were children, 30.2% were adults. Each study season, approximately half received influenza vaccine and one third experienced ≥1 ARI. The hazard of influenza in individuals during the 14-day post-vaccination period was similar to unvaccinated individuals during the same period (HR 0.96, 95% CI [0.60, 1.52]). The hazard of non-influenza respiratory pathogens was higher during the same period (HR 1.65, 95% CI [1.14, 2.38]); when stratified by age the hazard remained higher for children (HR 1·71, 95% CI [1.16, 2.53]) but not for adults (HR 0.88, 95% CI [0.21, 3.69]).

conclusionAmong children there was an increase in the hazard of ARI caused by non-influenza respiratory pathogens post-influenza vaccination compared to unvaccinated children during the same period. Potential mechanisms for this association warrant further investigation. Future research could investigate whether medical decision-making surrounding influenza vaccination may be improved by acknowledging patient experiences, counseling regarding different types of ARI, and correcting the misperception that all ARI occurring after vaccination are caused by influenza.

Indexed as

VaccinationAdolescentAdultChildChild, PreschoolFemaleHumansInfantInfluenza, HumanInfluenza VaccinesMaleMiddle AgedPerceptionProportional Hazards ModelsPublic Health SurveillanceRegistriesInfluenza VaccinesAcute respiratory illnessBeliefInfluenzaInfluenza vaccineMisperceptions

Identifiers

PMID29525279
PMCPMC7115556
OpenAlexW2793431217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.